{"title":"银陈好汤联合蓝光照射治疗新生儿病理性黄疸的疗效及安全性观察","authors":"Fang Dai, H. Shao","doi":"10.3760/CMA.J.ISSN.1008-6706.2020.05.011","DOIUrl":null,"url":null,"abstract":"Objective \nTo explore the efficacy and safety of Yinchenhao Decoction combined with blue light irradiation in the treatment of neonatal pathological jaundice. \n \n \nMethods \nFrom January 2018 to October 2018, a total of 94 neonates with pathological jaundice admitted to our hospital were divided into the control group and the observation group, with 47 cases in each group.On the basis of conventional treatment, the control group was given blue light irradiation treatment, while the observation group was treated with Yinchenhao Decoction on the basis of the control group.The changes of TBIL, UCB, TBA and HS-CRP levels, β-GD levels, clinical efficacy and incidence of adverse events were compared between the two groups after 7 days of treatment. \n \n \nResults \nAfter 7 days of treatment, the TBIL, UCB, TBA and HS-CRP levels in the observation group were (116.4±6.9)μmol/L, (153.6±8.2)μmol/L, (8.3±1.3)μmol/L, (4.9±0.6)mg/L, respectively, which were lower than those in the control group [(153.6±8.2)μmol/L, (249.3±42.3)μmol/L, (25.9±2.9)μmol/L, (18.3±0.5)mg/L] (t=15.851, 20.329, 9.624, 7.508, all P<0.05). The β-GD level reduced more significant in the observation group, which in both two groups were decreased after treatment (all P<0.05). The total effective rate of the observation group was 97.9%(46/47), which was significantly higher than that of the control group[85.1%(40/47)], and the total incidence of adverse reactions in the observation group was 4.3%(2/47), which was significantly lower than that in the control group[29.8%(17/47)], the differences were statistically significant(χ2=11.562, 14.605, all P<0.01). \n \n \nConclusion \nYinchenhao Decoction combined with blue light irradiation is effective in the treatment of neonatal pathological jaundice, possibly by affecting β-GD levels.In addition, it can significantly reduce the incidence of adverse reactions in children, with better efficacy and higher safety.It is worthy of clinical reference and promotion. \n \n \nKey words: \nJaundice, neonatal; Drugs, Chinese herbal; Balneology; Color therapy; Bilirubin; Bile acids and salts; C-reactive protein; Aldehyde dehydrogenase; Comparative study","PeriodicalId":10226,"journal":{"name":"中国基层医药","volume":"27 1","pages":"559-562"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and safety of Yinchenhao Decoction combined with blue light irradiation in the treatment of neonatal pathological jaundice\",\"authors\":\"Fang Dai, H. Shao\",\"doi\":\"10.3760/CMA.J.ISSN.1008-6706.2020.05.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo explore the efficacy and safety of Yinchenhao Decoction combined with blue light irradiation in the treatment of neonatal pathological jaundice. \\n \\n \\nMethods \\nFrom January 2018 to October 2018, a total of 94 neonates with pathological jaundice admitted to our hospital were divided into the control group and the observation group, with 47 cases in each group.On the basis of conventional treatment, the control group was given blue light irradiation treatment, while the observation group was treated with Yinchenhao Decoction on the basis of the control group.The changes of TBIL, UCB, TBA and HS-CRP levels, β-GD levels, clinical efficacy and incidence of adverse events were compared between the two groups after 7 days of treatment. \\n \\n \\nResults \\nAfter 7 days of treatment, the TBIL, UCB, TBA and HS-CRP levels in the observation group were (116.4±6.9)μmol/L, (153.6±8.2)μmol/L, (8.3±1.3)μmol/L, (4.9±0.6)mg/L, respectively, which were lower than those in the control group [(153.6±8.2)μmol/L, (249.3±42.3)μmol/L, (25.9±2.9)μmol/L, (18.3±0.5)mg/L] (t=15.851, 20.329, 9.624, 7.508, all P<0.05). The β-GD level reduced more significant in the observation group, which in both two groups were decreased after treatment (all P<0.05). The total effective rate of the observation group was 97.9%(46/47), which was significantly higher than that of the control group[85.1%(40/47)], and the total incidence of adverse reactions in the observation group was 4.3%(2/47), which was significantly lower than that in the control group[29.8%(17/47)], the differences were statistically significant(χ2=11.562, 14.605, all P<0.01). \\n \\n \\nConclusion \\nYinchenhao Decoction combined with blue light irradiation is effective in the treatment of neonatal pathological jaundice, possibly by affecting β-GD levels.In addition, it can significantly reduce the incidence of adverse reactions in children, with better efficacy and higher safety.It is worthy of clinical reference and promotion. \\n \\n \\nKey words: \\nJaundice, neonatal; Drugs, Chinese herbal; Balneology; Color therapy; Bilirubin; Bile acids and salts; C-reactive protein; Aldehyde dehydrogenase; Comparative study\",\"PeriodicalId\":10226,\"journal\":{\"name\":\"中国基层医药\",\"volume\":\"27 1\",\"pages\":\"559-562\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国基层医药\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1008-6706.2020.05.011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国基层医药","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1008-6706.2020.05.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Efficacy and safety of Yinchenhao Decoction combined with blue light irradiation in the treatment of neonatal pathological jaundice
Objective
To explore the efficacy and safety of Yinchenhao Decoction combined with blue light irradiation in the treatment of neonatal pathological jaundice.
Methods
From January 2018 to October 2018, a total of 94 neonates with pathological jaundice admitted to our hospital were divided into the control group and the observation group, with 47 cases in each group.On the basis of conventional treatment, the control group was given blue light irradiation treatment, while the observation group was treated with Yinchenhao Decoction on the basis of the control group.The changes of TBIL, UCB, TBA and HS-CRP levels, β-GD levels, clinical efficacy and incidence of adverse events were compared between the two groups after 7 days of treatment.
Results
After 7 days of treatment, the TBIL, UCB, TBA and HS-CRP levels in the observation group were (116.4±6.9)μmol/L, (153.6±8.2)μmol/L, (8.3±1.3)μmol/L, (4.9±0.6)mg/L, respectively, which were lower than those in the control group [(153.6±8.2)μmol/L, (249.3±42.3)μmol/L, (25.9±2.9)μmol/L, (18.3±0.5)mg/L] (t=15.851, 20.329, 9.624, 7.508, all P<0.05). The β-GD level reduced more significant in the observation group, which in both two groups were decreased after treatment (all P<0.05). The total effective rate of the observation group was 97.9%(46/47), which was significantly higher than that of the control group[85.1%(40/47)], and the total incidence of adverse reactions in the observation group was 4.3%(2/47), which was significantly lower than that in the control group[29.8%(17/47)], the differences were statistically significant(χ2=11.562, 14.605, all P<0.01).
Conclusion
Yinchenhao Decoction combined with blue light irradiation is effective in the treatment of neonatal pathological jaundice, possibly by affecting β-GD levels.In addition, it can significantly reduce the incidence of adverse reactions in children, with better efficacy and higher safety.It is worthy of clinical reference and promotion.
Key words:
Jaundice, neonatal; Drugs, Chinese herbal; Balneology; Color therapy; Bilirubin; Bile acids and salts; C-reactive protein; Aldehyde dehydrogenase; Comparative study
期刊介绍:
Since its inception, the journal "Chinese Primary Medicine" has adhered to the development strategy of "based in China, serving the grassroots, and facing the world" as its publishing concept, reporting a large amount of the latest medical information at home and abroad, prospering the academic field of primary medicine, and is praised by readers as a medical encyclopedia that updates knowledge. It is a core journal in China's medical and health field, and its influence index (CI) ranks Q2 in China's academic journals in 2022. It was included in the American Chemical Abstracts in 2008, the World Health Organization Western Pacific Regional Medical Index (WPRIM) in 2009, and the Japan Science and Technology Agency Database (JST) and Scopus Database in 2018, and was included in the Wanfang Data-China Digital Journal Group and the China Academic Journal Comprehensive Evaluation Database.